Trial Profile
The Effect Of Cabergoline On Folicular Microenviroment Profile In Patients With High Risk Of Ohss
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2022
Price :
$35
*
At a glance
- Drugs Cabergoline (Primary)
- Indications Ovarian hyperstimulation syndrome; Polycystic ovary syndrome
- Focus Pharmacodynamics
- 13 Apr 2012 New trial record